Jena, Germany

Michael Oettell

This inventor holds 1 USPTO granted patent. Top assignee: Veb Jenapharm. Active years: 1981.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Oettell: Innovator in Hormonal Compounds

Introduction

Michael Oettell is a notable inventor based in Jena, Germany. He has made significant contributions to the field of pharmaceutical preparations, particularly in the development of hormonal compounds. His work focuses on creating new chemical entities that have valuable biological properties.

Latest Patents

Oettell holds a patent for "Gona-4,9(10)-dienes and process of producing the same." This patent describes new gona-4,9(10)-dienes of a specific formula, where R represents an alkyl group of 1 to 3 carbon atoms and X can be various substituents such as Cl, Br, F, and others. The compounds developed through this patent exhibit important hormonal and antihormonal effects, making them useful in treating endocrinopathies and for reproduction control in both humans and livestock.

Career Highlights

Michael Oettell is associated with Veb Jenapharm, where he has been instrumental in advancing research in hormonal compounds. His innovative approach has led to the development of processes that convert specific chemical precursors into valuable pharmaceutical products.

Collaborations

Oettell has worked alongside notable colleagues such as Kurt Ponsold and Michael Hubner. Their collaborative efforts have contributed to the success of various projects within the pharmaceutical domain.

Conclusion

Michael Oettell's contributions to the field of hormonal compounds highlight his innovative spirit and dedication to advancing pharmaceutical science. His patent and collaborative work continue to influence the development of effective treatments in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…